HAVRIX AD 1440 VACUNA C/1 JERINGA PRELLENADA CARBOXIMETILCELULOSA SODICA 0.5% Hiperplasia gingival

Description

Hiperplasia gingival

Tratamiento de la hepatitis C crónica en adultos

Suplemento alimenticio como parte de un plan nutricional supervisado

PRINCIPIO ACTIVO: NIFUROXAZIDA

HAVRIX AD 1440 VACUNA C/1 JERINGA PRELLENADA CARBOXIMETILCELULOSA SODICA 0.5% Hiperplasia gingivalCaja C 1 Jeringa Prellenada

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy